AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 11266237
Drug: Nebulizer therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nebulizer therapy
Trial: 11266237
Drug: High-dose inhaler
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose inhaler therapy
Trial: 3075178
Drug: Calcitonin (daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcitonin (daily 100 MRC of salmon calcitonin intramuscularly)
Trial: 3075178
Drug: Cimetidine (daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine (daily 1000 mg orally)
Trial: 3075178
Drug: Colloidal bismuth
RxNorm normalized name: Colloidal bismuth subcitrate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Colloidal bismuth subcitrate (De‐Nol - four times a day in doses of 5 ml diluted with 15 ml of water)
Trial: 27691376
Drug: MOMCare (choice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MOMCare (choice of brief interpersonal psychotherapy, pharmacotherapy, or both)
Trial: 16440422
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg lansoprazole o.d.
Trial: 16440422
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg lansoprazole b.i.d.
Trial: 16440422
Drug: Both treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both treatment groups (30 mg lansoprazole o.d. and 30 mg lansoprazole b.i.d.)
Trial: 11151743
Drug: Quercetin aglycone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quercetin aglycone (8 mg, 20 mg, 50 mg)
Trial: 11151743
Drug: Rutin (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rutin (8 mg, 20 mg, 50 mg)
Trial: 9380609
Drug: 2.4 g
RxNorm normalized name: ZINC OXIDE 12.4 g in 100 g TOPICAL CREAM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.4 g of piracetam combined with cognitive therapy
Trial: 9380609
Drug: 4.8 g
RxNorm normalized name: ALCOHOL 74.8 g in 100 g TOPICAL SWAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4.8 g of piracetam combined with cognitive therapy
Trial: 29742587
Drug: Probenecid (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probenecid (25 mg/kg) and N-acetylcysteine (140 mg/kg)
Trial: 19549743
Drug: GHR antagonist
RxNorm normalized name: Interleukin-1 receptor antagonist anakinra
DrugBank: Anakinra (DB00026)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: GHR antagonist (pegvisomant, 10 mg/d)
Trial: 14984181
Drug: Ozonated autohemotherapy
RxNorm normalized name: ozone
DrugBank: Ozone (DB12510)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ozonated autohemotherapy (50 microg/ml)
Trial: 28760246
Drug: FDC 0.4/5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FDC 0.4/5 mg
Trial: 28760246
Drug: FDC 0.2/5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FDC 0.2/5 mg
Trial: 26018348
Drug: CNI-free de
RxNorm normalized name: sangre de grado
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CNI-free de novo immunosuppressive treatment (mycofenolate mofetil, steroids, basiliximab) with delayed introduction of sirolimus
Trial: 19031934
Drug: Severe (grade
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Severe (grade 3 or 4) hematological toxicity during chemotherapy
Trial: 19031934
Drug: No severe
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No severe myelotoxicity during chemotherapy
Trial: 10634823
Drug: alpha-tocopherol supplementation
RxNorm normalized name: alpha tocopherol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: alpha-tocopherol supplementation (50 mg daily)
Trial: 10634823
Drug: beta-carotene supplementation
RxNorm normalized name: Beta Carotene
DrugBank: Beta carotene (DB06755)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: beta-carotene supplementation (20 mg daily)
Trial: 8430681
Drug: Verapamil (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verapamil (80 mg twice a day)
Trial: 29178491
Drug: Etrolizumab (0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etrolizumab (0.3 to 10 mg/kg, administered intravenously or subcutaneously)
Trial: 19032127
Drug: Fixed combination
RxNorm normalized name: Progestogens and estrogens, fixed combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed combination treatments (budesonide/formoterol and salmeterol/fluticasone with terbutaline as needed)
Trial: 8737097
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose warfarin and aspirin
Trial: 8466726
Drug: Isradipine plus
RxNorm normalized name: Isradipine
DrugBank: Isradipine (DB00270)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isradipine plus spirapril 3 mg
Trial: 8466726
Drug: Isradipine plus
RxNorm normalized name: Isradipine
DrugBank: Isradipine (DB00270)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isradipine plus pindolol 5 mg
Trial: 8466726
Drug: Overall treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Overall treatment with isradipine
Trial: 8466726
Drug: Side-effects related
RxNorm normalized name: cured fat, pork side bacon
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Side-effects related to treatment
Trial: 22742205
Drug: IV montelukast
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV montelukast 7 mg
Trial: 22742205
Drug: IV montelukast
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV montelukast 14 mg
Trial: 22742205
Drug: IV montelukast
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV montelukast 7 mg and 14 mg
Trial: 20299485
Drug: 800 mg
RxNorm normalized name: bran 800 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 800 mg NCX 4016 b.i.d.
Trial: 20299485
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of NCX 4016 and aspirin
Trial: 18853112
Drug: Langchuang No.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Langchuang No.1 or 2 (Chinese recipes) in addition to Western medicine
Trial: 16422913
Drug: Vardenafil 10
RxNorm normalized name: vardenafil 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vardenafil 10 mg, flexible-dose regimen (5 mg or 20 mg possible after 4 weeks)
Trial: 1997509
Drug: Inhaled budesonide
RxNorm normalized name: budesonide Inhalation Suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled budesonide (3.2 mg/day)
Trial: 1997509
Drug: Inhaled budesonide
RxNorm normalized name: budesonide Inhalation Suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled budesonide (0.8 mg/day)
Trial: 1997509
Drug: Oral prednisolone
RxNorm normalized name: prednisolone Oral Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral prednisolone (40 mg/day)
Trial: 1997509
Drug: Oral prednisolone
RxNorm normalized name: prednisolone Oral Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral prednisolone (10 mg/day)
Trial: 1997509
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose prednisolone (40 mg/day)
Trial: 1997509
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose prednisolone (10 mg/day)
Trial: 6426828
Drug: Sodium valproate
RxNorm normalized name: sodium valproate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium valproate (DPA) 400 mg
Trial: 31092654
Drug: Medical grade
RxNorm normalized name: Skarcade Medical Grade Silicone Matrix
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medical grade kanuka honey (90%)/glycerine (10%) cream
Trial: 29408453
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg RAPA daily
Trial: 20133153
Drug: Four SES
RxNorm normalized name: Four-Way
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Four SES risk factors (low monthly income, less than a college education, unmarried, unemployed)
Trial: 12205255
Drug: SIMV+VG 4.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SIMV+VG 4.5 (V(T mech) set at 4.5 mL/kg)
Trial: 12205255
Drug: SIMV+VG 3.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SIMV+VG 3.0 (V(T mech) set at 3.0 mL/kg)
Trial: 7723681
Drug: Nibbling diet
RxNorm normalized name: phentermine hydrochloride Oral Capsule [T-Diet]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nibbling diet (17 meals daily)
Trial: 7723681
Drug: Control diet
RxNorm normalized name: phentermine hydrochloride Oral Capsule [T-Diet]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control diet (3 meals daily)
Trial: 6352383
Drug: Levamisole (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levamisole (150 mg orally once weekly)
Trial: 28550255
Drug: Sembragiline 1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sembragiline 1 mg
Trial: 28550255
Drug: Sembragiline 5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sembragiline 5 mg
Trial: 23383224
Drug: Amoxicillin/clavulanate potassium
RxNorm normalized name: Amoxicillin/Clavulanate Potassium 250 MG-125 MG Oral Tablet
DrugBank: Amoxicillin (DB01060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amoxicillin/clavulanate potassium (A/CP)
Trial: 19769010
Drug: Skipping medications
RxNorm normalized name: piperonyl butoxide / pyrethrins Medicated Shampoo [Stop Lice Maximum Strength]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Skipping medications
Trial: 17680222
Drug: Pulsed-dose-rate (PDR)
RxNorm normalized name: tacrolimus
DrugBank: Tacrolimus (DB00864)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pulsed-dose-rate (PDR) brachytherapy, prescribed reference dose of 49.8 Gy in 83 fractions of 0.6 Gy every hour, total treatment time 3-4 days.
Trial: 17680222
Drug: High-dose-rate (HDR)
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose-rate (HDR) brachytherapy, prescribed reference dose of 32 Gy in eight fractions of 4 Gy, twice daily.
Trial: 15197804
Drug: Zoledronic acid
RxNorm normalized name: Zoledronic Acid
DrugBank: Zoledronic acid (DB00399)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Zoledronic acid 8/4 mg
Trial: 11224833
Drug: MnCC vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MnCC vaccine (4 doses at 2, 4, 6 months)
Trial: 11224833
Drug: MnCC vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MnCC vaccine (after Dose 3)
Trial: 11224833
Drug: MnCC vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MnCC vaccine (after Dose 4)
Trial: 11224833
Drug: MnCC vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MnCC vaccine (after three doses)
Trial: 11224833
Drug: MnCC vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MnCC vaccine (after booster)
Trial: 11224833
Drug: 7-valent conjugate
RxNorm normalized name: PNEUMOCOCCAL 7-VALENT CONJUGATE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7-valent conjugate pneumococcal vaccine (control)
Trial: 7994879
Drug: Goserelin depot
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Goserelin depot (3.6 mg) administered monthly for 6 months (n = 22)
Trial: 7994879
Drug: Goserelin depot
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Goserelin depot (3.6 mg) administered monthly for 12 months (n = 8)
Trial: 7994879
Drug: Goserelin depot
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Goserelin depot (3.6 mg) administered for 3 months
Trial: 973959
Drug: Pindolol (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pindolol (5 mg t.d.s. for 5 days)
Trial: 30423641
Drug: Wallis implant
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Wallis implant after lumbar discectomy
Trial: 21500885
Drug: Cognitive-behavioral analysis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioral analysis system of psychotherapy (CBASP) plus pharmacotherapy
Trial: 21500885
Drug: Brief supportive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Brief supportive psychotherapy (BSP) plus pharmacotherapy
Trial: 19062268
Drug: Endocrine therapy
RxNorm normalized name: ENDOCRINE THERAPY
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endocrine therapy (toremifene or tamoxifen)
Trial: 19062268
Drug: Chemo-endocrine therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemo-endocrine therapy (CMF or AC plus toremifene or tamoxifen)
Trial: 17409581
Drug: Standard therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard therapy for heart failure
Trial: 11464037
Drug: 3 mg
RxNorm normalized name: boron 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 mg apomorphine SL
Trial: 11464037
Drug: 4 mg
RxNorm normalized name: lutein 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg apomorphine SL
Trial: 8089245
Drug: Chlorhexidine (0.12%)
RxNorm normalized name: chlorhexidine 12 MG
DrugBank: Chlorhexidine (DB00878)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chlorhexidine (0.12%) rinses, 15 ml, 2 times daily for 1 month
Trial: 8089245
Drug: Placebo solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo solution rinses
Trial: 3385044
Drug: Indomethacin therapy
RxNorm normalized name: Indomethacin
DrugBank: Indomethacin (DB00328)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Indomethacin therapy (double-blind, controlled, crossover trial in 14 patients)
Trial: 18390799
Drug: Higher-dose oral
RxNorm normalized name: BENZOCAINE 50 mg in 1 mL TOPICAL GEL [HIGHER CONTROL Male Climax Control Lubricating]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher-dose oral contraceptive pill (OCP) (35 microg ethinyl estradiol/2 mg cyproterone acetate)
Trial: 7577204
Drug: High-dose cyclophosphamide,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose cyclophosphamide, cisplatin, and carmustine with autologous bone marrow support
Trial: 7577204
Drug: Low-dose cyclophosphamide,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-dose cyclophosphamide, cisplatin, and carmustine
Trial: 1663851
Drug: Therapy for
RxNorm normalized name: nutritional therapy for GSD
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Therapy for back pain
Trial: 28421317
Drug: Oral nutritional
RxNorm normalized name: Ocean Blue Nutritionals Omega-3 1450 Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral nutritional supplement (ONS) - 250 ml of Arginaid Water ingested in the evening before the experiment and at 7:00 am on the day of the experiment.
Trial: 28421317
Drug: Oral nutritional
RxNorm normalized name: Ocean Blue Nutritionals Omega-3 1450 Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral nutritional supplement (ONS) - 250 ml of Arginaid Water.
Trial: 21219660
Drug: Ipratropium bromide
RxNorm normalized name: Ipratropium Bromide
DrugBank: Ipratropium (DB00332)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ipratropium bromide 80 mcg and albuterol 400 mcg
Trial: 19395131
Drug: Isohumulones 32
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isohumulones 32 mg
Trial: 19395131
Drug: Isohumulones 48
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isohumulones 48 mg
Trial: 19395131
Drug: Isohumulones 16
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isohumulones 16 mg
Trial: 17948074
Drug: Ascorbic acid
RxNorm normalized name: Ascorbic Acid
DrugBank: Ascorbic acid (DB00126)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ascorbic acid (2 g on the night before surgery and 1 g twice daily for 5 days after surgery)
Trial: 12202015
Drug: Naltrexone 50
RxNorm normalized name: naltrexone 50 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naltrexone 50 mg qd plus sertraline 50 mg qd
Trial: 12202015
Drug: Naltrexone 50
RxNorm normalized name: naltrexone 50 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naltrexone 50 mg qd with placebo
Trial: 10414911
Drug: G-CSF (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: G-CSF (5 microg/kg/day)
Trial: 9818688
Drug: Both G-CSF
RxNorm normalized name: G-CSF
DrugBank: Lenograstim (DB13144)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both G-CSF and GM-CSF
Trial: 8580921
Drug: Topical retinoic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical retinoic acid (n = 32)
Trial: 30939922
Drug: Automated hovering
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Automated hovering intervention with patient-level incentives for daily weight monitoring and diuretic adherence, combined with automated feedback into the clinical care pathway.
Trial: 27817819
Drug: FF 100
RxNorm normalized name: APAP 325/CAFF 100/ISOMETHEPTENE 65MG CAP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FF 100 μg OD
Trial: 27817819
Drug: FP 100
RxNorm normalized name: Peanut Allergen-dnfp 100 MG Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FP 100 μg BD
Trial: 27817819
Drug: FP 250
RxNorm normalized name: Coagulation Factor IX (Recombinant), Albumin Fusion Protein (rIX-FP)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FP 250 μg BD
Trial: 27817819
Drug: FF/VI 100/25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FF/VI 100/25 μg OD
Trial: 24809261
Drug: Neuromuscular blocking
RxNorm normalized name: Neuromuscular blocking agent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neuromuscular blocking agents (NMBA) - vecuronium, loading dose of 0.1 mg/kg, continuous infusion of 0.05 mg/kg/h for 24-48 hours
Trial: 24809261
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no NMBA treatment)
Trial: 19318295
Drug: Diclofenac epolamine
RxNorm normalized name: Diclofenac Epolamine
DrugBank: Diclofenac (DB00586)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Diclofenac epolamine patch
Trial: 17311621
Drug: Viusid (three
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Viusid (three sachets daily) + IFN alpha‐2b (5 MU on alternate days) + ribavirin (13 mg/kg daily)
Trial: 17311621
Drug: IFN alpha‐2b
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IFN alpha‐2b (5 MU on alternate days) + ribavirin (13 mg/kg daily)
Trial: 17311621
Drug: Standard therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard therapy (without Viusid)
Trial: 15500398
Drug: Oxypurinol added
RxNorm normalized name: Stahist AD
DrugBank: Chlorcyclizine (DB08936)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oxypurinol added to standard therapy
Trial: 11174617
Drug: Early indomethacin
RxNorm normalized name: Indomethacin
DrugBank: Indomethacin (DB00328)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early indomethacin treatment (3 x 0.2 mg/kg every 12 hours, starting on day 3)
Trial: 11174617
Drug: Early indomethacin
RxNorm normalized name: Indomethacin
DrugBank: Indomethacin (DB00328)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early indomethacin treatment
Trial: 11174617
Drug: Late indomethacin
RxNorm normalized name: Indomethacin
DrugBank: Indomethacin (DB00328)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Late indomethacin treatment (starting on day 7)
Trial: 3387686
Drug: Dipyridamole 100
RxNorm normalized name: dipyridamole 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dipyridamole 100 mg and acetylcysteine 100 mg every 6 h
Trial: 3387686
Drug: Acetylcysteine 100
RxNorm normalized name: acetylcysteine 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetylcysteine 100 mg every 6 h
Trial: 28150367
Drug: 2.5% benzoyl
RxNorm normalized name: BENZOYL PEROXIDE 2.5 g in 100 mL TOPICAL SOAP [Benzoyl Acne Wash -2.5% Benzoyl Peroxide]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5% benzoyl peroxide gel
Trial: 2143890
Drug: Hepatic arterial
RxNorm normalized name: Sus scrofa artery preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hepatic arterial infusion (HAI) chemotherapy
Trial: 2143890
Drug: Intravenous (i.v.)
RxNorm normalized name: immunoglobulins, intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous (i.v.) administration
Trial: 7285484
Drug: d-amphetamine 25
RxNorm normalized name: amphetamine / dextroamphetamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: d-amphetamine 25 mg
Trial: 7285484
Drug: Control (0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (0 mg d-amphetamine)
Trial: 25351237
Drug: 0.5 µg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 µg/kg DEX in 10 mL isotonic saline (group II)
Trial: 25351237
Drug: 1.0 µg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.0 µg/kg DEX in 10 mL isotonic saline (group III)
Trial: 25351237
Drug: 10 mL
RxNorm normalized name: Vial Empty 10 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mL isotonic saline (group I)
Trial: 17021811
Drug: Continued thiamazole
RxNorm normalized name: thiamazole
DrugBank: Methimazole (DB00763)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Continued thiamazole medication (11.0+/‐7.0 mg/day)
Trial: 17021811
Drug: Discontinuation of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Discontinuation of thiamazole for 2 days
Trial: 17021811
Drug: Discontinuation of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Discontinuation of thiamazole for 1 day
Trial: 9780135
Drug: Intranasal cocaine
RxNorm normalized name: Cocaine
DrugBank: Cocaine (DB00907)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal cocaine administration
Trial: 9780135
Drug: Smoked cocaine
RxNorm normalized name: Cocaine
DrugBank: Cocaine (DB00907)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Smoked cocaine administration
Trial: 7825033
Drug: PBMC co-cultivated
RxNorm normalized name: Cultivated mushroom
DrugBank: Cultivated mushroom (DB10544)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PBMC co-cultivated with phytohemagglutinin‐P activated PBMC from healthy, HIV‐1 antibody negative donors
Trial: 29288250
Drug: High-dose vitamin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose vitamin D3 (250,000 or 500,000 IU)